149 related articles for article (PubMed ID: 2825557)
1. [T-activin in the combined therapy of patients with benign ovarian tumors].
Griaznova IM; Makarov OV; Arion VIa; Epeĭkina TN
Akush Ginekol (Mosk); 1987 Jul; (7):28-31. PubMed ID: 2825557
[No Abstract] [Full Text] [Related]
2. [Taktivin in the combined treatment of patients with ovarian cancer].
Griaznova IM; Makarov OV; Arion VIa; Kerbikova VF; Epeĭkina TN
Akush Ginekol (Mosk); 1988 Aug; (8):57-61. PubMed ID: 3195710
[No Abstract] [Full Text] [Related]
3. The consequences of unsuspected secondary ovarian neoplasia: a clinical presentation of four case histories.
Roley KM; Reza Hafez G; Buchler DA
Gynecol Oncol; 1990 Feb; 36(2):277-80. PubMed ID: 2153625
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy in the treatment of cancer of the ovary.
Smith JP; Rutledge F
Am J Obstet Gynecol; 1970 Jul; 107(5):691-703. PubMed ID: 4316665
[No Abstract] [Full Text] [Related]
5. [Principles of immunocorrective therapy using the thymus preparation T-activin].
Arion VIa; Ivanushkin EF
Khirurgiia (Mosk); 1984 Nov; (11):44-8. PubMed ID: 6335205
[No Abstract] [Full Text] [Related]
6. [Effect of T-activin and irradiation with a helium-neon laser on the status of the interleukin-2-dependent component of the proliferative response of mononuclear cells in rheumatoid arthritis].
Parnes EIa; Alikhanov BA; Tkomachev IuK; Muromtsev AV
Fiziol Cheloveka; 1995; 21(4):143-9. PubMed ID: 7589960
[No Abstract] [Full Text] [Related]
7. [Clinical effectiveness of thymus preparations (T-activin, thymalin) in erysipelas infection].
Frolov VM; Peresadin NA; Pustovoĭ IuG; Gaĭdash IS; Tishchenko NA; Gavrilova LA; Pinskiĭ LL
Sov Med; 1990; (6):111-3. PubMed ID: 2144365
[No Abstract] [Full Text] [Related]
8. [The use of T-activin in the intensive therapy of the postoperative period in gestosis patients].
Ianiushina VV
Anesteziol Reanimatol; 1992; (4):42-5. PubMed ID: 1485674
[TBL] [Abstract][Full Text] [Related]
9. [Endovascular surgery and the validation of immunocorrection in patients with liver cirrhosis complicated by portal hypertension].
Karimov ShI; Kim VF; Iunusov IR
Vestn Khir Im I I Grek; 1991 May; 146(5):26-8. PubMed ID: 1668432
[TBL] [Abstract][Full Text] [Related]
10. [Dynamics of the immune status of patients with mycosis of the feet and concomitant eczema during T-activin therapy].
Iutskovskiĭ AD; Fedotov VP; Leshchenko GM
Vestn Dermatol Venerol; 1986; (7):17-21. PubMed ID: 3765804
[No Abstract] [Full Text] [Related]
11. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients.
Stanojević-Bakić N; Milosević D; Vucković-Dekić L; Sasić M; Marković L
Neoplasma; 1996; 43(4):245-52. PubMed ID: 8931749
[TBL] [Abstract][Full Text] [Related]
12. [Experience in the use of T-activin in patients with malignant testicular tumors and patients with kidney cancer].
Geveling NV; Zhogoleva IB
Vopr Onkol; 1986; 32(8):98-103. PubMed ID: 2429445
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of ovarian cancer. New approaches to treatment.
Smith JP; Rutledge F; Wharton JT
Cancer; 1972 Dec; 30(6):1565-71. PubMed ID: 4345098
[No Abstract] [Full Text] [Related]
14. The effect of using T-activin in the therapy of the newborn with suppurative surgical infection.
Samsygin SA; Dolgina EN; Arion VYa ; Romanova LA; Shchevochkina GI; Ovchinnikova EA
J Hyg Epidemiol Microbiol Immunol; 1989; 33(3):269-76. PubMed ID: 2809182
[TBL] [Abstract][Full Text] [Related]
15. Metastatic ovarian cancer.
Smith JP; Rutledge FN
Clin Obstet Gynecol; 1973 Jun; 16(2):286-97. PubMed ID: 4351522
[No Abstract] [Full Text] [Related]
16. [The clinico-immunological effects of T-activin in the combined treatment of patients with acute suppurative pyelonephritis].
Vozianov AF; Drannik GN; Pasechnikov SP; Driianskaia VE; Petrovskaia IA; Kushko LIa; Ozvinchuk II; Potrebinskiĭ VM; Milinevskiĭ VA
Lik Sprava; 1995; (9-12):81-3. PubMed ID: 8983802
[TBL] [Abstract][Full Text] [Related]
17. [Effects of T-activin on the immunological status of middle-aged and aged patients after gastric resection and selective proximal vagotomy in complicated duodenal ulcer].
Ataliev AE; Faĭn SI; Eliseeva MR
Klin Khir (1962); 1990; (5):50-1. PubMed ID: 2391907
[No Abstract] [Full Text] [Related]
18. [Clinical effectiveness of T-activin in the treatment of cutaneous forms of lupus erythematosus].
Skripkin IuK; Biriukov AV; Stenina MA; Skripnik AIu; Korotkiĭ NG
Vestn Dermatol Venerol; 1985 May; (5):8-11. PubMed ID: 3898631
[No Abstract] [Full Text] [Related]
19. [The role of neutrophils in the pathogenesis of psoriasis and the effect of T-activin on them].
Korotkiĭ NG; Udzhukhu VIu; Vasil'eva LL; Redchenko EB; Bagandov TI
Vestn Dermatol Venerol; 1987; (7):19-22. PubMed ID: 3673241
[No Abstract] [Full Text] [Related]
20. [Experimental rationale for the use of T-activin for correction of immunodeficiency in the treatment of periapical inflammation].
Volozhin AI; Arion VIa; Zyrianov GV; Krotova SB; Sysoeva OB
Patol Fiziol Eksp Ter; 1994; (2):19-20. PubMed ID: 8078682
[No Abstract] [Full Text] [Related]
[Next] [New Search]
